Coagulase-negative staphylococcal infections in a neonatal intensive care unit: In vivo response to cloxacillin

Paediatrics and Child Health

Volumn 11, Issue 10, 2006, Pages 659-663

  Blayney, Marc P ^a,b   Al Madani, Mahmud ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

^b NORTHERN ONTARIO SCHOOL OF MEDICINE   (Canada)

Author keywords

Antibiotic sensitivities; Coagulase negative staphylococcal bacteremia; Very low birth weight

Indexed keywords

CLOXACILLIN; GENTAMICIN; PENICILLIN BINDING PROTEIN 2A; RIFAMPICIN; VANCOMYCIN;

ARTICLE; BACTEREMIA; BACTERIUM ISOLATION; COAGULASE POSITIVE STAPHYLOCOCCUS; CONTROLLED STUDY; DATA BASE; DRUG SENSITIVITY; DRUG USE; FEMALE; GESTATIONAL AGE; HUMAN; IN VIVO STUDY; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NEWBORN INTENSIVE CARE; PATHOGENESIS; PATIENT IDENTIFICATION; SEPSIS; STAPHYLOCOCCUS INFECTION; TREATMENT OUTCOME; TREATMENT RESPONSE; VERY LOW BIRTH WEIGHT;

EID: 33846427701     PISSN: 12057088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Isaacs D. Rationing antibiotic use in neonatal units. Arch Dis Child Fetal Neonatal Ed 2000;82:F1-2.
2. Recommendations for preventing the spread of vancomycin resistance. Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep 1995;44(RR-12):1-13.
3. Centers for Disease Control and Prevention (CDC). Staphylococcus aureus resistant to vancomycin - United States, 2002. MMWR Morb Mortal Wkly Rep 2002;51:565-7.
4. Lawrence S, Roth V, Slinger R, Toye B, Tierney M, Lemyre B. Cloxacillin versus vancomycin for presumed late-onset sepsis in the NICU: Impact of CONS sepsis outcomes. Paediatr Child Health 2002;7(Suppl A):30A. (Abst)
5. Isaacs D, Moxon R. Handbook of Neonatal Infections: A Practical Guide. London: WB Saunders, 1999.
6. Kaiser JR, Cassat JE, Lewno MJ. Should antibiotics be discontinued at 48 hours for negative late-onset sepsis evaluations in the neonatal intensive care unit? J Perinatol 2002;22:445-7.
7. Stoll BJ, Hansen N, Fanaroff AA, et al. Late-onset sepsis in very low birth weight neonates: The experience of the NICHD Neonatal Research Network. Pediatrics 2002;110:285-91.
8. Horbar JD, Rogowski J, Plsek PE, et al. Collaborative quality improvement for neonatal intensive care. NIC/Q Project Investigators of the Vermont Oxford Network. Pediatrics 2001;107:14-22.
9. Karlowicz MG, Buescher ES, Surka AE. Fulminant late-onset sepsis in a neonatal intensive care unit, 1988-1997, and the impact of avoiding empiric vancomycin therapy. Pediatrics 2000;106:1387-90.
10. Struthers S, Underbill H, Albersheim S, Greenberg D, Dobson S. A comparison of two versus one blood culture in the diagnosis and treatment of coagulase-negative staphylococcus in the neonatal intensive care unit. J Perinatol 2002;22:547-9.
11. Khadilkar V, Tudehope D, Fraser S. A prospective study of nosocomial infection in a neonatal intensive care unit. J Paediatr Child Health 1995;31:387-91.
12. Rubin LG, Sanchez PJ, Siegel J, et al. Evaluation and treatment of neonates with suspected late-onset sepsis: A survey of neonatologists' practices. Pediatrics 2002;110:e42.
13. Kumar Y, Qunibi M, Neal TJ, Yoxall CW. Time to positivity of neonatal blood cultures. Arch Dis Child Fetal Neonatal Ed 2001;85:F182-6.
14. Allen TR, da Silva OP. Choice of antibiotics in late onset sepsis in the extremely low birthweight infant. Can J Infect Dis 2003;14:28-31.
15. Matrai-Kovalskis Y, Greenberg D, Shinwell ES, Fraser D, Dagan R. Positive blood cultures for coagulase-negative staphylococci in neonates: Does highly selective vancomycin usage affect outcome? Infection 1998;26:85-92.
16. Krediet TG, Jones ME, Gerards LJ, Fleer A. Clinical outcome of cephalothin versus vancomycin therapy in the treatment of coagulase-negative staphylococcal septicemia in neonates: Relation to methicillin resistance and mec A gene carriage of blood isolates. Pediatrics 1999;103:E29.
17. Pickering LK, Baker CJ, Overturf GD, Prober CG; American Academy of Pediatrics. Red Book: Report of the Committee on Infectious Diseases, 26th edn. Elk Grove Village, Illinois: American Academy of Pediatrics, 2003.
18. Woods W, Ramotar K, Lem P, Toye B. Oxacillin susceptibility testing of coagulase-negative staphylococci using the disk diffusion method and the Vitek GPS-105 card (small star, filled). Diagn Microbiol Infect Dis 2002;42:291-4.
19. Gradelski E, Valera L, Aleksunes L, Bonner D, Fung-Tomc J. Correlation between genotype and phenotypic categorization of staphylococci based on methicillin susceptibility and resistance. J Clin Microbiol 2001;39:2961-3.
20. National Committee for Clinical Laboratory Standards. Approved Standards M7-A5, M100-S10. Performance Standards for Antimicrobial Disk Susceptibility Tests: Approved Standards, 7th edn. Wayne, Pennsylvania: National Committee for Clinical Laboratory Standards, 2001.
21. Severin A, Tabei K, Tenover F, Chung M, Clarke N, Tomasz A. High level oxacillin and vancomycin resistance and altered cell wall composition in Staphylococcus aureus carrying the staphylococcal mecA and the enterococcal vanA gene complex. J Biol Chem 2004;279:3398-407.